Company / Depreciation & Amortization
Ginkgo Bioworks Holdings, Inc. Depreciation & Amortization History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$59.0M
FY2025
5-year range
$29.1M / $70.5M
FY2021-FY2025
Trend
-6.4%
vs FY2024
Sector context
#29 of 162
Health Care
What the data says
Ginkgo Bioworks Holdings, Inc.'s depreciation & amortization of $59M is higher than 82% of companies in the Health Care sector (FY2025). Improved from $71M to $59M over the past 2 years.
Based on SEC 10-K filings.
$59M in FY2025 with a 5-year CAGR of +33.6%. Top quartile in the Health Care sector.
Improved from $71M to $59M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +11.5%
- 5-Year CAGR
- +33.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 162This company $59.0M Sector average $220.5M
▼
-73.3% below sector average
Key checks
Key Insights
- 5-year CAGR of +33.6%, indicating consistent growth.
- In FY2025, depreciation & amortization decreased 6.4% year-over-year.
- Ranks #29 out of 162 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $59.0M | -6.4% |
| FY2024 | $63.0M | -10.6% |
| FY2023 | $70.5M | +65.7% |
| FY2022 | $42.6M | +46.3% |
| FY2021 | $29.1M | +109.7% |
| FY2020 | $13.9M | +28.9% |
| FY2019 | $10.8M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026